PharmaSecure closes $3.9M

LOS ALTOS HILLS, CA – October 24, 2011

PharmaSecure Inc, a pioneer in pharmaceutical authentication technology, closed today on a $3.9 million investment from Eric Schmidt’s Innovation Endeavors, Gray Ghost Ventures, Healthtech Capital and the TEEC Angel Fund. The investments will be used to create new applications to respond to the Government of India’s drug serialization requirements that go into effect next year.

This year, the Directorate General of Foreign Trade of India mandated that all drugs exported from India must have unique serial numbers and barcodes by July 2012. India’s exports of pharmaceuticals are expected to reach $8 billion in 2012.

Since launching its India operations in 2009, PharmaSecure has printed over 65 million pharmaceutical packages with unique ID codes that allow consumer authentication by SMS. The company has agreements in place to protect over 1.5 billion pharmaceutical packages in India and exported from India over the next year; a number that continues to grow.

According to Innovation Endeavors’ Dror Berman, “We’ve invested in PharmaSecure because they are executing a game-changing approach to combating counterfeit drugs that holds huge potential for improving the safety and security of pharmaceutical products throughout the world.” With the pharmaceutical industry experiencing substantial growth in emerging markets, the counterfeit drug industry has also grown to capture roughly $75 billion of the global drug market. These counterfeit drugs pose a major health threats that can results in death, illness and drug resistance among users. PharmaSecure guards against counterfeit drugs by printing on each bubble pack of pills a unique code and phone number so consumers can verify the drug’s authenticity with an SMS text message.

“India is leading the way in the global fight against counterfeit drugs. We are proud to have had a hand in creating applications like SMS authentication that put the power of protection against dangerous medicine literally in people’s hands,” said PharmaSecure co-founder and CEO Nathan Sigworth. “We are investing in more applications that can ride on the mandated serialization to increase the reach and distribution of our clients’ products and better health for their consumers. With the tradition of innovation that comes with this investment we expect the regulatory requirements to provide a creative opportunity for us and our clients.”

PharmaSecure’s innovative, cost-effective method earned the company Fast Company’s designation as one of the “10 Most Innovative Companies in Health Care.”

About PharmaSecure

PharmaSecure is a global innovator in drug authentication technologies and software, creating effective solutions to ensure consumers receive authentic medications from trusted pharmaceutical manufacturers in emerging markets. Founded in 2007, PharmaSecure is a fast-growing company offering services in the United States, Europe, India, Africa, and Southeast Asia.

About HealthTech Capital

HealthTech Capital is a leading Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market where digital innovation improves healthcare delivery and empowers patients. HealthTech Capital is led by proven investors and visionaries in health care and technology. Its members are industry leaders – successful entrepreneurs, executives, physicians and venture capitalists – with expertise in healthcare and new information and mobile technologies. In addition to funding and mentoring new companies, the group facilitates syndication with other angel investors, venture capitalists and corporations for funding and other opportunities. For more information on HealthTech Capital, please visit www.HealthTechCapital.com.

 

EVENTS

17 March 2018 Boomer summit March 27-28, 2018

I’ll be one of the featured speakers at the What’s Next #Boomer Summit in San Francisco, CA. March 27-28 in San Francisco Use my 20% discount code: WH18FOM

04 March 2018 HAAS Healthcare Conference 2018

When: March 9, 2018 from 3 to 3:50pm

Location: SF Mission Bay Conference Center

  • 1675 Owens Street #251, San Francisco, CA, 94158

Panel: Consumerization 2.0

  • Anne DeGheest (our moderator) - Founder and Managing Director at HealthTech Capital and Medstars
  • Naomi Kelman - President and CEO at Willow,
  • Dr. Cameron Sepah - Founder and CEO at Actualize and Entrepreneur in Residence at Trinity Ventures, 
  • Adam Kovalevsky - SVP Product, Engineering, and Design at Collective Health 
  • Yasi Baiani - Head of Product Management, Software Experiences, Fitbit

04 March 2018 HIMSS 2018

HIMSS 2018

March 5-9, 2018
Venetian Palazzo, Las Vegas
http://www.himssconference.org/

March 7, 2018: 9:40 a.m. – 10:30 a.m.
Lidio 3104
Investor Perspective: The Healthcare Ecosystem

Investor Perspective: The Healthcare Ecosystem

Moderator: Lisa Suennen, GE Ventures
Speakers:
Lee Shapiro, 7Wire Ventures
Sumit Kumar Nagpal, FHIMSS, Managing Director, HealthBox, Co-Founder, LumiraDx, Chairman and CEO - CareFully, Inc
Brian Friedman - First Analysis
Anne DeGheest, HealthTech Capital

28 June 2017 Sensors Expo & Conference

Sensors Expo & Conference
Conference & Expo:
June 28-29, 2017
Pre-Conference Symposia: June 27, 2017
McEnery Convention Center
San Jose, CA
www.sensorsexpo.com

$100 discount with code HTC100


RSS

© 2011 HealthTech Capital. All Rights Reserved. Designed by Night River